AT302545B - Verfahren zur Herstellung von reinem Vitamin D3 - Google Patents

Verfahren zur Herstellung von reinem Vitamin D3

Info

Publication number
AT302545B
AT302545B AT166470A AT166470A AT302545B AT 302545 B AT302545 B AT 302545B AT 166470 A AT166470 A AT 166470A AT 166470 A AT166470 A AT 166470A AT 302545 B AT302545 B AT 302545B
Authority
AT
Austria
Prior art keywords
production
pure vitamin
vitamin
pure
Prior art date
Application number
AT166470A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AT302545B publication Critical patent/AT302545B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT166470A 1969-02-25 1970-02-24 Verfahren zur Herstellung von reinem Vitamin D3 AT302545B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH280469 1969-02-25

Publications (1)

Publication Number Publication Date
AT302545B true AT302545B (de) 1972-10-25

Family

ID=4241955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT166470A AT302545B (de) 1969-02-25 1970-02-24 Verfahren zur Herstellung von reinem Vitamin D3

Country Status (11)

Country Link
US (1) US3665020A (de)
JP (1) JPS494931B1 (de)
AT (1) AT302545B (de)
BE (1) BE746403A (de)
DE (1) DE2004280C3 (de)
DK (1) DK129653B (de)
FR (1) FR2033012A5 (de)
GB (1) GB1290576A (de)
IT (1) IT954062B (de)
NL (1) NL146490B (de)
SE (1) SE350252B (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114369047A (zh) * 2022-01-27 2022-04-19 重庆迈德凯医药有限公司 一种结晶维生素d3的方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217288A (en) * 1977-03-24 1980-08-12 Wisconsin Alumni Research Foundation Anti-vitamin D compounds
US4419287A (en) * 1980-12-16 1983-12-06 The Regents Of The University Of California Stereocontrolled synthesis of steroidal side chains
US6362350B1 (en) * 1999-07-01 2002-03-26 Wisconsin Alumni Research Foundation Crystalline 1α, 24(S)-dihydroxyvitamin D2 and method of purification thereof
WO2007011951A2 (en) * 2005-07-18 2007-01-25 Teva Pharmaceutical Industries Ltd. Purification of paricalcitol
US20070093458A1 (en) * 2005-07-18 2007-04-26 Anchel Schwartz Preparation of paricalcitol and crystalline forms thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114369047A (zh) * 2022-01-27 2022-04-19 重庆迈德凯医药有限公司 一种结晶维生素d3的方法

Also Published As

Publication number Publication date
GB1290576A (de) 1972-09-27
FR2033012A5 (de) 1970-11-27
NL7001794A (de) 1970-08-27
IT954062B (it) 1973-08-30
US3665020A (en) 1972-05-23
DE2004280A1 (de) 1970-09-10
NL146490B (nl) 1975-07-15
DK129653B (da) 1974-11-04
DK129653C (de) 1975-04-14
DE2004280B2 (de) 1974-11-21
BE746403A (fr) 1970-08-24
DE2004280C3 (de) 1975-07-17
JPS494931B1 (de) 1974-02-04
SE350252B (de) 1972-10-23

Similar Documents

Publication Publication Date Title
CH535831A (de) Verfahren zur Herstellung von L-Lysin
CH544093A (de) Verfahren zur Herstellung von O-Acyl-lysergolen
AT302973B (de) Verfahren zur Herstellung von Mikrokapseln
AT302989B (de) Verfahren zur Herstellung von Bromnitroalkoholen
AT298629B (de) Verfahren zur Herstellung von Indoanilinen
AT300371B (de) Verfahren zur Herstellung von Polyurethanen
AT301506B (de) Verfahren zur Herstellung von Glycerin
CH543553A (de) Verfahren zur Herstellung von Poly-amid-imid-estern
AT302545B (de) Verfahren zur Herstellung von reinem Vitamin D3
AT306715B (de) Verfahren zur Herstellung von ω-Lactamen
DE2045819B2 (de) Verfahren zur herstellung von aeruginoinsaeure
AT300840B (de) Verfahren zur Herstellung von Organo-H-silanen
AT298453B (de) Verfahren zur Herstellung von Trimethylhydrochinon
CH543487A (de) Verfahren zur Herstellung von Adamantylharnstoffen
CH544808A (de) Verfahren zur Herstellung von Negamycin
AT301504B (de) Verfahren zur Herstellung von Alkoholen
CH516991A (de) Verfahren zur Herstellung von Presskörpern
CH522012A (de) Verfahren zur Herstellung von Polyurethanen
AT301505B (de) Verfahren zur Herstellung von Glycerin
CH544758A (de) Verfahren zur Herstellung von Lysergolen
CH504530A (de) Verfahren zur Herstellung von Cytidin-diphosphat-cholin
CH497425A (de) Verfahren zur Herstellung von B-Picolin
CH523774A (de) Verfahren zur Herstellung von Pressteilen
CH542845A (de) Verfahren zur Herstellung von Vitamin B6
AT303960B (de) Verfahren zur herstellung von alpha-aminobenzylpenicillin

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee